EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

IV MEROPENEM CAUSED MARKED ELEVATION OF ALT & ALP IN CRITICALY ILL PATIENT: A CASE REPORT

Muhammad Qamar*, Ahmad Mahmud, Amiruddin Ahmad and Jiyauddin Khan

ABSTRACT

A 37 year old Malay man admitted in GICU for intra-abdominal sepsis secondary to perforated appendix and had undergone multiple laparotomy. He had no known past-medical history and his father was died of colon cancer. In the GICU, he was treated with high dose of IV Meropenem for two weeks. There were sudden increased from baseline in patient alanine transaminase (ALT) and alkaline phosphatase (ALP) five days after the initiation of therapy. Naranjo causality assessment was 5, indicated probable adverse drug reaction. IV Meropenem was then stopped after two weeks from the initiation of therapy and it was noted that serum level of ALT and ALP were gradually decreased.

Keywords: Meropenem, Liver enzymes, Alanine transaminase and Alkaline phosphatase.

[Full Text Article] [Download Certificate]